Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and effects on histamine-induced wheal of PF-05180999 in healthy adults; the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• PF-05180999

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 1 | Status: TERMINATED